Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of SHACT (topical lidocaine) for hysteroscopy in women
2013-001775-20Phase 2Completed
- Sponsor
- PharmaNest
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lidocaine in procedural pain, sponsored by PharmaNest. Primary endpoints: Feasibility of using SHACT for hysteroscopy and Handling properties of SHACT and instillation device. Started May 2013; status: completed.
02
Drugs
lidocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on 2013-001775-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001775-20.